Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) insider Catriona Yale sold 597 shares of the firm’s stock in a transaction dated Thursday, December 14th. The stock was sold at an average price of $20.76, for a total value of $12,393.72. Following the sale, the insider now owns 77,910 shares of the company’s stock, valued […]